+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Clinical Trial Market Size, Share and Growth Outlook, 2026: Analysis By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Phase (Phase I, Phase II, Phase III, Phase IV), By Service Type (In-House Services, Outsourced Services ), By Indication (Oncology, Central Nervous System , Cardiovascular Diseases, Autoimmune & Inflammatory Diseases, Infectious Diseases, Metabolic Disorders , Ophthalmology & Dermatology), By End-User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Academic and Government Research Bodies) Companies, and Country Forecast, 2021 to 2034

Global Clinical Trial Market size is forecast to increase from $101.86 Billion in 2026 to $185.76 Billion in 2034 at a CAGR of 7.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006437
Pages: 210 Pages

Clinical Trial Management Services Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Site Identification and Selection, Clinical Monitoring, Data Management, Regulatory and Ethics Committee Support, Pharmacovigilance and Safety Reporting, Project Management and Coordination), By Phase (Phase I, Phase II, Phase III, Phase IV), By Therapeutic Area (Oncology, Cardiology, Neurology, Infectious Diseases, Metabolic Disorders, Immunology), By End User (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Contract Research Organizations , Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Clinical Trial Management Services Market size is forecast to increase from $42.63 Billion in 2026 to $84.32 Billion in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006436
Pages: 225 Pages

Clinical Trial Kits Market Size, Share and Growth Outlook, 2026: Analysis By Product Type: (Sample Collection Kits , Diagnostic Kits , Drug Administration, Monitoring Kits , Smart), By Application: (Small Molecule Trials, Large Molecule Trials, Biologics, Cell Therapy, Gene Therapy, Medical Device Trials), By Phase: (Phase I, Phase II, Phase III, Phase IV), By End-Use: (Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations , Research Universities, Medical Research Centers) Companies, and Country Forecast, 2021 to 2034

Global Clinical Trial Kits Market size is forecast to increase from $2.59 Billion in 2026 to $5.14 Billion in 2034 at a CAGR of 8.94% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006435
Pages: 210 Pages

Clinical Trial Investigative Site Network Market Size, Share and Growth Outlook, 2026: Analysis By Site Type: (Academic Medical Centers, Community Hospitals, Dedicated Site Networks, Retail-Health Clinics, Private Physician Sites), By Therapeutic Area: (Oncology, Cardiology, Central Nervous System , Pain Management, Endocrine Disorders, Rare & Orphan Diseases, Infectious Diseases), By Phase: (Phase I, Phase II, Phase III, Phase IV, Early-Access), By End-Use: (Sponsors, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Clinical Trial Investigative Site Network Market size is forecast to increase from $10.22 Billion in 2026 to $19.1 Billion in 2034 at a CAGR of 8.13% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006434
Pages: 221 Pages

Clinical Trial Imaging Market Size, Share and Growth Outlook, 2026: Analysis By Service and Software: (Operational Imaging Services, Read and Analytical Services, System and Technical Support Services, Trial Design and Consulting Services, Software), By Modality: (Computed Tomography , Magnetic Resonance Imaging , Ultrasound, Positron Emission Tomography , X-Ray, Others), By Therapeutic Area: (Oncology, Cardiovascular System Disorders, Neurology, Endocrinology, Infectious Diseases, Immunological Disorders, Others), By End-User: (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations , Academic & Government Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Clinical Trial Imaging Market size is forecast to increase from $1.49 Billion in 2026 to $2.81 Billion in 2034 at a CAGR of 8.26% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006433
Pages: 224 Pages

Clinical Trial Equipment and Ancillary Solutions Market Size, Share and Growth Outlook, 2026: Analysis By Offering Type (Sourcing and Procurement , Rental and Leasing , Supply and Logistics , Maintenance and Calibration Services, Ancillary Supplies ), By Equipment Category (Laboratory Equipment , Patient Monitoring Equipment , Dosing and Infusion Devices, Diagnostic Imaging Equipment, Specialized Storage and Cold Chain Units), By Phase (Phase I, Phase II, Phase III, Phase IV), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations , Medical Device Companies, Clinical Research Sites and Investigator Sites) Companies, and Country Forecast, 2021 to 2034

Global Clinical Trial Equipment and Ancillary Solutions Market size is forecast to increase from $4.32 Billion in 2026 to $8.75 Billion in 2034 at a CAGR of 9.22% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006432
Pages: 227 Pages

Clinical Trial Consumables Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Investigational Medicinal Products , Placebos, Laboratory Consumables , Specialized Kits , Temperature-Controlled Packaging Materials), By Phase (Bioavailability , Phase I, Phase II, Phase III, Phase IV ), By Therapeutic Area (Oncology, Cardiovascular Diseases, Central Nervous System , Infectious Diseases, Metabolic & Autoimmune Disorders, Rare & Orphan Diseases), By End-User (Pharmaceutical Companies, Biologics & Biotech Firms, Contract Research Organizations , Academic & Medical Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Clinical Trial Consumables Market size is forecast to increase from $5.76 Billion in 2026 to $11.39 Billion in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006431
Pages: 215 Pages

Clinical Trial Central Laboratory Services Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Safety Testing , Biomarker Testing and Validation, Genomic and Molecular Testing , Anatomic Pathology and Histology, Microbiology and Immunology Services, Pharmacokinetics and Pharmacodynamics , Bioanalytical Services), By Phase (Phase I, Phase II, Phase III, Phase IV), By Modality (Small Molecules, Biologics, Cell and Gene Therapy), By Indication (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders, Immunology and Autoimmune Diseases), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations , Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Clinical Trial Central Laboratory Services Market size is forecast to increase from $5.24 Billion in 2026 to $10.67 Billion in 2034 at a CAGR of 9.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006430
Pages: 212 Pages

Clinical Trial Biorepository and Archiving Solutions Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Biorepository Services , Archiving Services , Digital Data Management and e-Archiving, Sample Management & Logistics, Ancillary Services ), By Biospecimen Type (Blood and Blood Components, Human Tissues and Biopsies, Cells and Cell Lines , Nucleic Acids , Organs and Other Biological Samples), By Phase (Pre-clinical, Phase I, Phase II, Phase III, Phase IV), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations , Academic and Research Institutes, Diagnostic Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Clinical Trial Biorepository and Archiving Solutions Market size is forecast to increase from $6.43 Billion in 2026 to $12.57 Billion in 2034 at a CAGR of 8.74% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006429
Pages: 228 Pages

Clinical Risk Grouping Solutions Market Size, Share and Growth Outlook, 2026: Analysis By Product: (Dashboard Analytics, Scorecard and Data Visualization Tools, Risk Reporting Solutions), By Deployment Model: (Private Cloud, Public Cloud, Hybrid Cloud), By End-User: (Hospitals, Payers, Ambulatory Surgical Centers, Long-Term Care Centers) Companies, and Country Forecast, 2021 to 2034

Global Clinical Risk Grouping Solutions Market size is forecast to increase from $991.74 Million in 2026 to $2809.23 Million in 2034 at a CAGR of 13.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006428
Pages: 226 Pages